Complete Genomics (an MGI company) released the DNBSEQ-G400 into the U.S. market this summer. DNBSEQ-G400 is a benchtop sequencer that uses MGI’S DNA Nanoball sequencing technology (DNBSEQ) that boasts low index hopping, low amplification bias, and low PCR amplification error accumulation. In addition, the instrument is capable of using an improved antibody-based chemistry, CoolMPS sequencing reagent, that reduces errors and improves the sequencing quality.
Read type and length
DNBSEQ-G400 is a short-read sequencer with a variety of read lengths and options, including SE50, SE100, SE400, PE100, PE150, PE200, and PE300. The run times vary from 13 to 58 hours depending on the selected flow cell, read lengths, and cycle kit.
Flow cell/SMRT cell options
There are two flow cell options, FCS and FCL, and users have the ability to run one or two independent flow cells per run. The FCS flow cell comes equipped with two lanes and the FCL has a total of four lanes. Each of the lanes can be loaded independently. There are also two options (StandardMPS and CoolMPS) for sequencing reagents. The StandardMPS can be used with any flow cell type, but the CoolMPS can only be used with the FCL flow cell.
Data output
The DNBSEQ-G400 can produce 55–1440 Gb of data per run, depending on the reagent type, read lengths, flow cell types, and number of flow cells used. The expected number of reads varies from 300M–550 M reads with a single FCS flow cell to 1500–2000 M reads with a single FCL flow cell.
Analysis options
Barcode demultiplexing and FASTQ generation are completed on the machine and are accounted for in the run times. Secondary analysis can be completed using external analysis tools or done with MGI’s MegaBOLT bioinformatics analysis accelerator. MegaBOLT includes existing framework for analysis of whole genome sequencing, whole exome sequencing, and panel sequencing with germline or somatic data.
Common applications
● Microbial detection
● Single-cell sequencing
● Cancer panels
● Whole exome and genome sequencing
● 16S sequencing
Release date
Officially released in the U.S. in August, DNBSEQ-G400 is currently available for use, while three other sequencers are pending for release in the coming year (DNBSEQ-E25, DNBSEQ-T7, and DNBSEQ-T10x4). Sequencers and supplies from Complete Genomics (MGI) may have different availabilities and release schedules for customers in other countries.
Highlights
● Customizable sequencing with many options for flow cells, read lengths, and reagent type.
● Low PCR error amplification, low amplification bias, and low index hopping.
● Wide range of available applications along with streamlined analysis from MegaBOLT bioinformatics software.
● Shorter time from sequencing to FASTQ generation.
● Improved base calling and reduced molecular scarring with CoolMPS reagent.
To compare sequencing technologies please visit Biocompare
Seqanswers Leaderboard Ad
Collapse
X
Collapse
About the Author
Collapse
Benjamin Atha holds a B.A. in biology from Hood College and an M.S. in biological sciences from Towson University. With over 9 years of hands-on laboratory experience, he's well-versed in next-generation sequencing systems. Ben is currently the editor for SEQanswers.
Find out more about seqadmin
Latest Articles
Collapse
-
by seqadmin
The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist...-
Channel: Articles
04-22-2024, 07:01 AM -
-
by seqadmin
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...-
Channel: Articles
04-04-2024, 04:25 PM -
-
by seqadmin
Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...-
Channel: Articles
03-22-2024, 06:39 AM -
ad_right_rmr
Collapse
News
Collapse